Literature DB >> 7240256

Absence of proteoglycan core protein in cartilage from the cmd/cmd (cartilage matrix deficiency) mouse.

K Kimata, H J Barrach, K S Brown, J P Pennypacker.   

Abstract

Mice homozygous for the autosomal recessive gene, cartilage matrix deficiency (cmd/cmd), are characterized by disproportionate dwarfism and cleft palate. The collagen and proteoglycan of fetal limb cartilage was examined by biochemical and immunofluorescent techniques. While a normal amount of type II collagen was found, the amount of proteoglycan was reduced as determined by chemical analysis and incorporation of labeled precursors. Analyses of labeled proteoglycans by glycerol density gradient centrifugation under dissociative conditions and by gel filtration showed that the major high molecular weight proteoglycan characteristic of cartilage was absent, but smaller proteoglycans were present in normal amounts. Antibodies directed against proteoglycan core protein failed to stain the cmd/cmd cartilage while antibodies to type II collagen stained the cartilage without hyaluronidase pretreatment. Addition of beta-D-xyloside, an exogenous substrate for chondroitin sulfate synthesis, and direct assay for beta-D-xylosyltransferase activity indicated that cmd/cmd cartilage cells contained normal levels of the enzymes required for chondroitin sulfate synthesis. The data suggest that cmd/cmd is defective in the synthesis of the cartilage proteoglycan core protein.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240256

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Molecular heterogeneity in chondrodysplasias.

Authors:  P H Byers
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

2.  Aggrecan is expressed by embryonic brain glia and regulates astrocyte development.

Authors:  Miriam S Domowicz; Timothy A Sanders; Clifton W Ragsdale; Nancy B Schwartz
Journal:  Dev Biol       Date:  2008-01-22       Impact factor: 3.582

3.  Abnormal ambient glucose levels inhibit proteoglycan core protein gene expression and reduce proteoglycan accumulation during chondrogenesis: possible mechanism for teratogenic effects of maternal diabetes.

Authors:  C M Leonard; M Bergman; D A Frenz; L A Macreery; S A Newman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Dwarfism and age-associated spinal degeneration of heterozygote cmd mice defective in aggrecan.

Authors:  H Watanabe; K Nakata; K Kimata; I Nakanishi; Y Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Altered proteoglycan synthesis by micromelial limbs induced by 6-aminonicotinamide. Appearance of abnormal forms of cartilage-characteristic proteoglycan (PG-H).

Authors:  A Honda; S Kazuno; Y Mori; K Kimata; S Suzuki
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

Review 6.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

7.  Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development.

Authors:  Christopher B Little; Clare T Meeker; Rosalind M Hembry; Natalie A Sims; Kate E Lawlor; Sue B Golub; Karena Last; Amanda J Fosang
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 8.  Chondrodysplasia of gene knockout mice for aggrecan and link protein.

Authors:  Hideto Watanabe; Yoshihiko Yamada
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  Cell kinetics of growth cartilage in spondylo-metaphyseal chondrodysplasia (smc) mice.

Authors:  M N Thurston; D R Johnson; N F Kember
Journal:  J Anat       Date:  1985-05       Impact factor: 2.610

10.  Animal cell mutants defective in glycosaminoglycan biosynthesis.

Authors:  J D Esko; T E Stewart; W H Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.